Straumann Emdogain celebrates 25 years of success
Celebrating 25 years of success in the industry, Straumann® Emdogain® is an easy-to-use, biomimetic biology-based gel containing Enamel Matrix Derivative (EMD), that can be used for periodontal regeneration, gingival recession and wound healing.
It promotes the regeneration of soft tissue formation for accelerated wound healing and reduces risk of complications. For over two decades it has been the gold standard in regenerative periodontology and promotes patient comfort whilst reducing post-surgical swelling.
Straumann Emdogain provides an effective way of regenerating lost tissue in a minimally invasive way [1,2]. It can be used in periodontal pockets of up to 9mm as part of a highly effective non-surgical periodontal hygiene protocol . Backed by 25 years of clinical experience and over 1,000 scientific publications (including 600 clinical studies) it provides peace of mind for complex cases, increases patient comfort and predictability and induces true regeneration.
Available from the comprehensive Straumann Group portfolio of biomaterials, Straumann Emdogain has already proven its worth for more than two decades. With continued investment and development, it looks set to be around for another 25 years to come!
For more information on the complete range of biomaterials, please visit www.straumann-uk.co/biomaterials
1] Shujaa Addin A, Akizuki T, Mat- suura T, Hoshi S, Ikawa T, Maruyama K, Ono W, Fukuba S, Izumi Y. Histological healing after nonsurgical periodontal treatment with enamel matrix derivatives in canine experimental periodontitis. Odontology. 2018 Jul;106(3):289-296
2] Mellonig JT, Valderrama P, Gregory HJ, Cochran DL. Clinical and histologic evaluation of non-surgical periodontal therapy with enamel matrix derivative: a report of four cases. J Periodontol. 2009 Sep;80(9):1534-40
3] Graziani F, Gennai S, Petrini M, Bettini L, Tonetti M. Enamel matrix derivative stabilizes blood clot and improves clinical healing in deep pockets after flapless periodontal therapy: A Randomized Clinical Trial. J Clin Periodontol. 2019 Feb;46(2):231-240